Exchange Announcement • 09 Nov 2022 21:00
Q3 2022
Exchange Announcement • 24 Aug 2022 08:00
Q2 2022
Exchange Announcement • 09 May 2022 08:00
Q1 2022
Exchange Announcement • 04 Mar 2022 08:00
Q4 2021
Exchange Announcement • 12 Nov 2021 08:00
𝛼SK or SearchENTITY
Bavarian Nordic A/S (BAVA DC)
Bavarian Nordic A/S (BAVA DC)
10
Analysis
Health Care • Denmark
Bavarian Nordic A/S operates as a biotechnology company. The Company focuses on research, development, and manufacture of novel cancer immunotherapies and vaccines for infectious diseases. Bavarian Nordic operates worldwide.
morex